Education
About Us
Working with TipRanks
Follow Us
Waters Corp. (GB:0LTI)
LSE:0LTI
Earnings Data
Report Date
Aug 05, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
2.93Last Year’s EPS
2.63Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 06, 2025
|% Change Since: -4.19%
|Next Earnings Date:Aug 05, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth across key segments such as Pharma and PFAS testing, driven by robust demand and innovative products. Despite challenges from newly announced tariffs and a cautious outlook for the U.S. Academic & Government segment, Waters Corporation raised its full-year guidance, reflecting confidence in its ability to navigate current market conditions.Company Guidance
During the Waters Corporation First Quarter 2025 Financial Results Conference Call, the company outlined its guidance for the second quarter and full-year 2025. Waters projected a constant currency sales growth of 5% to 7% for the full year, driven by robust demand in the pharmaceutical and industrial sectors. Instrument sales saw an 11% growth, with liquid chromatography and mass spectrometry sales achieving mid-teens growth, bolstered by significant contributions from Pharma and industrial markets. Additionally, the company expects a high single-digit earnings growth despite new tariffs, aided by strong pricing strategies and operational efficiencies. The guidance also reflects a constant currency EPS growth of 10% to 12%, with a raised full-year adjusted EPS guidance between $12.75 and $13.05. Waters anticipates continued momentum in its core markets, particularly in high-volume applications such as GLP-1 and PFAS testing, and a 20% revenue growth in India, underscoring its resilience and strategic positioning in the face of dynamic global challenges.Strong Instrument Growth
Instruments grew 11%, led by mid-teens sales growth in both liquid chromatography and mass spectrometry with strength driven by Pharma and industrial end markets.
Pharma Sales Boost
Pharma sales grew 8%, with double-digit growth in Asia and the Americas, driven by strong demand in large Pharma, generics, and CDMOs.
PFAS Testing Surge
PFAS-related testing sales grew over 90% in the first quarter, continuing a strong growth trend as LC-MS becomes the dominant technique for regulated analysis.
India Growth
The India team delivered revenue growth close to 20% in constant currency, driven by strong demand from generics manufacturers and CDMOs.
Increased Full-Year Guidance
Full-year constant currency sales growth guidance raised to 5% to 7%, with adjusted EPS guidance increased to a range of $12.75 to $13.05.
---
GB:0LTI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
GB:0LTI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| May 06, 2025 | $351.72 | $337.00 | -4.19% |
| Feb 12, 2025 | $402.76 | $376.57 | -6.50% |
| Nov 01, 2024 | $324.20 | $383.84 | +18.39% |
| Jul 31, 2024 | $323.12 | $334.95 | +3.66% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Waters Corp. (GB:0LTI) report earnings?
Waters Corp. (GB:0LTI) is schdueled to report earning on Aug 05, 2025, TBA Not Confirmed.
What is Waters Corp. (GB:0LTI) earnings time?
Waters Corp. (GB:0LTI) earnings time is at Aug 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Waters Corp. stock?
The P/E ratio of Waters is N/A.
What is GB:0LTI EPS forecast?
GB:0LTI EPS forecast for the fiscal quarter 2025 (Q2) is 2.93.
---